Subbaram Manoj V, MacRae Scott M
Bausch & Lomb, Rochester, NY. USA.
J Refract Surg. 2007 May;23(5):435-41. doi: 10.3928/1081-597X-20070501-03.
To develop and test the efficacy of myopic treatment, based on preoperative manifest refraction and higher order aberrations, in enhancing the postoperative refractive error following customized LASIK treatment and compare results with the manufacturer-recommended sphere offset Zyoptix treatment nomogram, which does not account for the preoperative higher order aberrations.
One hundred seventy-five myopic eyes (89 patients) were treated based on the Rochester nomogram, which specified the amount of myopia to be treated based on preoperative manifest refraction and higher order aberrations, including third order aberrations and spherical aberration. Postoperative refractive error was measured at 1 month and compared to that theoretically estimated with the Zyoptix nomogram.
The mean preoperative sphere and cylinder were -4.52 +/- 2.05 diopters (D) and -0.81 +/- 0.70 D, respectively. The mean postoperative spheres were +0.04 +/- 0.33 D and +0.31 +/- 0.54 D, using the Rochester and Zyoptix nomograms, respectively. The mean postoperative spherical equivalent refractions were -0.11 +/- 0.34 D and +0.15 +/- 0.53 D using the Rochester and Zyoptix nomograms, respectively. The Rochester nomogram reduced the range of postoperative spherical equivalent to +/- 1.00 D, which was significantly better than that using the Zyoptix nomogram (t = 5.46, P < .0001), which would have resulted in 8% of eyes with a postoperative spherical equivalent refraction > +/- 1.00 D. Using the Rochester nomogram, 93.1% of eyes attained a postoperative UCVA > or = 20/20. The percentage of postoperative hyperopic overcorrection decreased to 2.8% in the Rochester nomogram group from 22.3% using the Zyoptix nomogram, which only adjusts spherical values based on preoperative sphere and does not account for preoperative aberrations.
The Rochester nomogram compensates for the effect of preoperative higher order aberrations on sphere and provided reduced range of postoperative spherical equivalent refraction.
基于术前显验光和高阶像差开发并测试近视治疗方法,以提高定制准分子原位角膜磨镶术(LASIK)治疗后的屈光不正,并将结果与制造商推荐的不考虑术前高阶像差的球镜偏移Zyoptix治疗列线图进行比较。
根据罗切斯特列线图对175只近视眼(89例患者)进行治疗,该列线图根据术前显验光和高阶像差(包括三阶像差和球差)确定要治疗的近视量。在术后1个月测量屈光不正,并与使用Zyoptix列线图理论估计的结果进行比较。
术前平均球镜和柱镜分别为-4.52±2.05屈光度(D)和-0.81±0.70 D。使用罗切斯特和Zyoptix列线图时,术后平均球镜分别为+0.04±0.33 D和+0.31±0.54 D。使用罗切斯特和Zyoptix列线图时,术后平均等效球镜屈光分别为-0.11±0.34 D和+0.15±0.53 D。罗切斯特列线图将术后等效球镜范围缩小至±1.00 D,明显优于使用Zyoptix列线图(t = 5.46,P <.0001),使用Zyoptix列线图会导致8%的眼睛术后等效球镜屈光>±1.00 D。使用罗切斯特列线图时,93.1%的眼睛术后最佳矫正视力(UCVA)≥20/20。罗切斯特列线图组术后远视过矫的百分比从使用Zyoptix列线图时的22.3%降至2.8%,Zyoptix列线图仅根据术前球镜调整球镜值,不考虑术前像差。
罗切斯特列线图可补偿术前高阶像差对球镜的影响,并减少术后等效球镜屈光的范围。